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The adult subventricular zone (SVZ) contains Nestin+ progenitors that differentiate mainly
into neuroblasts. Our previous data showed that interleukin-10 (IL-10) regulates SVZ
adult neurogenesis by up-regulating the expression of pro-neural genes and modulating
cell cycle exit. Here we addressed the specific mechanism through which IL-10 carries
out its signaling on SVZ progenitors. We found that, in vitro and in vivo, IL-10 targets
Nestin+ progenitors and activates the phosphorylation of ERK and STAT3. The action of
IL-10 on Nestin+ progenitors is reversed by treatment with a MEK/ERK inhibitor, thus
restoring neurogenesis to normal levels. Silencing STAT3 expression by lentiviral vectors
also impaired neurogenesis by blocking the effects of IL-10. Our findings unveil ERK and
STAT3 as effectors of IL-10 in adult SVZ neurogenesis.
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INTRODUCTION
Postnatal neurogenesis takes place in restricted regions or niches
in the adult brain. The SVZ lining the LVs is one of the main
neurogenenic niches in the adult brain. The niche is composed by
supporting cells, the vasculature and three progenitor cell types:
slow-cycling glial-like NSCs or type B cells (GFAP+); TACs or
type C cells (Ki67+, and Mash1+), and the more differentiated
neuroblasts (type A cells; PSA-NCAM+; DCX+; TUBB3+) that
migrate over long distances through theRMS to reach the olfactory
bulb, where they finally become mainly GABAergic interneu-
rons (Lois and Alvarez-Buylla, 1994; Doetsch and Alvarez-Buylla,
1996; Doetsch et al., 1997; Merkle et al., 2004; Ihrie et al., 2011).
Nestin labels type B and C cells and a sub-population of imma-
ture committed neuroblasts (Doetsch et al., 1997; Perez-Asensio
et al., 2013). The SVZ niche is unique in spatial localization and
molecular characteristics. The relationships between the differ-
ent cell types, the cerebrospinal fluid (CSF), and the vasculature
modulate the molecular signals that regulate self-renewal, prolif-
eration, the identity of VZ-SVZ-derived progeny, the integration
of some intrinsic mechanisms (Guillemot, 2007; Lim et al., 2009;
Ihrie et al., 2011).
Interleukin-10 (IL-10) is a general anti-inflammatory molecule
that contributes to maintaining the pro- and anti-inflammatory
balance in the body (Pestka et al., 2004; Saraiva and O’Garra, 2010;
Abbreviations: ICV, intracerebroventricular; LV, lateral ventricle; NICD, Notch
intracellular domain; NSC, neural stem cell; RMS, rostral migratory stream; SVZ,
subventricular zone; TAC, transit amplifying cell.
Ouyang et al., 2011). Recently, we demonstrated a new physi-
ological role of this cytokine as a relevant factor that regulates
postnatal neurogenesis. We deciphered how IL-10 targets the pop-
ulation of Nestin+ progenitors located in the dorsal SVZ, where
it regulates the expression of undifferentiated neural progenitor
markers, cell cycle activity, and the production of new neuroblasts
(Perez-Asensio et al., 2013).
Here we aimed to identify the specific intracellular mechanism
through which IL-10 acts specifically on adult Nestin+ progeni-
tors. Our results show that IL-10 regulates the activation of ERK
and STAT3 inNestin+progenitors and that this activity is required
for IL-10 to exert its actions on neural progenitors.
MATERIALS AND METHODS
RECOMBINANT PROTEINS, REAGENTS AND ANIMALS
Interleukin-10 was purchased from Prepotech (Rocky Hill, CT,
USA) and R&D (Minneapolis, MN, USA), and U0126 was from
Merck-Millipore (Darmstadt,Germany). Mice (C57BL/6) and rats
(Wistar) were obtained fromCharles River (Lyon, France). All ani-
mals were male and age-matched. Animals work was carried out
in accordance with the European Community Council Directives
on animal welfare and according to the local regulations. Every
effort was made to minimize animal suffering.
PRIMARY CULTURES
Cell cultures were performed from postnatal brains of rats (P7–
P9) as previously described (Perez-Asensio et al., 2013). Briefly,
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the SVZ was gently microdissected mildly trypsinized and platted
in poly-L-lysine coated plates and cultured in DMEM/F12 supple-
mented with B27 (Life Technologies, Paisley, UK) in the presence
or absence of IL-10 (50 ng/ml). Lentiviral vector production
and concentration was performed as described (Geraerts et al.,
2006). Transduction of primary cells was performed during 4–
6 h with 1 × 106 transducing units (TU)/ml. Cultures were fixed
in 4% paraformaldehyde (PFA), permeabilized with 0.1% triton
and stained as below. Nuclei were routinely counterstained with
Hoechst.
BIOCHEMISTRY
Western blotting of primary cultures and tissue samples were
processed as previously described (Perez-Asensio et al., 2013).
Membranes were then incubated with the following antibodies:
phosphorylated STAT1 and STAT3 (all from Cell Signaling Tech-
nology, 1:1000); DCX (Cell Signaling Technology 1:1000; Santa
Cruz Biotechnology, Santa Cruz, CA, USA 1:500), Nestin (1:500,
either fromMerck-Millipore or BDBioscience San Jose, CA,USA),
Musashi (Millipore, 1:500), Mash1 (BD Bioscience, 1:500), total
STAT-1 (BD transduction, 1:1000), total STAT-3 (BD Bioscience,
1:1000), Notch-ICD (Abcam, Cambridge, UK; 1:500), Numb
(Abcam, 1:500); and Tubulin (Sigma, 1:50000), or Actin (Sigma,
1:50000) as loading controls.
IMMUNOFLUORESCENCE
For immunofluorescence see procedure described Perez-Asensio
et al. (2013). The list and dilution of primary antibodies was:
pSTAT3ser727 (1:500), pERK1/2 (1:500), BIII-Tubulin (1:1000),
DCX (1:1000), Nestin (1:200), Ki67 (Leica Microsystems, Wet-
zlar, Germany 1:1000), BrdU (AbCam, 1:400), Olig2 (Millipore,
1:400), GFAP (DAKO, 1:2000). Staining on cell cultures was visu-
alized with a Leica CTR400-DMI400B inverted microscope or
Leica DM5500Q confocal microscope. Photographs were taken
by a DFC300FX camera from Leica. Quantification was carried
out using Leica Application Suite (LAS-Leica) or ImageJ (NIH)
software. The number of positive cells for each experimental assay
was expressed as percentage of the total number, and/or referred
as percentage of the control.
INTRACEREBROVENTRICULAR SUBSTANCE INFUSION IN THE MOUSE
BRAIN
The administrationof the IL-10 (50ng/ml) and/orU0126 (25μM)
at a low flow rate of 0.5 μl/h during 7 days in the third ven-
tricle was carried out by continuous infusion with an Alzet®
osmotic minipump (model 1007D) and Alzet® Brain Infusion Kit
3 (DURECT Corporation, Cupertino, CA, USA); see procedure in
Perez-Asensio et al. (2013). The delivery of saline as the vehicle or
IL-10 to the third ventricle was achieved by inserting the cannula
1.7 mm depth from the brain surface at −0.1 mm posterior, and
0.6 lateral coordinates (Franklin andPaxinos, 1997), after exposing
Bregma. The contralateral (ctr) hemisphere (left) was always con-
sidered for histological analysis and some ipsilateral hemispheres
were used for biochemical studies.
INTRACEREBRAL ADMINISTRATION OF LENTIVIRAL VECTORS
Some pump-implanted mice received, during the same surgery
operation, lentiviral particles (1 ul with 1 × 106 TU) in the ventral
striatum adjacent to the LV of left hemisphere at coordinates
1.7 mm depth from the brain surface at −0.1 mm posterior, and
0.6 lateral coordinates (Paxinos and Watson, 1998). Animals were
sacrificed 7 days after operation.
HISTOLOGY
See methodology in Perez-Asensio et al. (2013), briefly: mice
(8 weeks) were perfused with 4% PFA and cryoprotected in 30%
sucrose. Coronal sections (16 μm) were obtained and were col-
lected in eight consecutive slice series. In all animals, the left (ctr)
hemisphere was analyzed on histological sections.
Routinely, the total number of cells in dorsal SVZ was counted
per section after TO-PRO3 staining (Invitrogen). Cell death was
evaluated by the pattern of cleaved Spectrin by elecrophoresis
and Western blotting and cleaved Caspase 3 immunostaining on
sections (Cell Signaling, 1:150). After immunofluorescence analy-
sis (see protocol above), brain sectionswere scanned and evaluated
under a Leica DM5500Q confocal microscope. At least four con-
secutive sections from the same slice were evaluated for each
staining and the number of positive cells for each section was
counted after a Z projection by ImageJ or LAS (Leica application
suite) software. For the SVZ analysis, pictures were taken between
+1.10 and +0.38 mm from Bregma.
STATISTICAL ANALYSIS
Analyses of significant differences between group means were
performed using the two-tailed Student’s t-tests. In each case,
n indicates the number of independent cultures or mice used.
Statistical significance was considered always if p < 0.05.
RESULTS
IL-10 STIMULATES STAT3 PHOSPHORYLATION ON SVZ PROGENITORS
Our previous studies demonstrated that IL-10 receptor is present
in Nestin+ progenitors of the adult SVZ and that IL-10 reduces
neuronal differentiation by keeping progenitors in an active cycle
and up-regulating pro-neural gene markers (Nestin, Sox1, Sox2,
Musashi, Mash1; see Perez-Asensio et al., 2013). In the present
study, we aimed to decipher the intracellular mechanism activated
by IL-10 in SVZ progenitors.
Interaction of IL-10 with IL-10R1 followed by JAK1-mediated
tyrosine phosphorylation of STAT3 is required for IL-10 to exert
its anti-inflammatory activity (Ouyang et al., 2011). Stimula-
tion assays with IL-10 on SVZ-dissociated cultures showed a
rapid phosphorylation of STAT3 on Ser727 (pSTAT3ser727), while
pSTAT3tyr705 was not induced (Figure 1A). IL-10 did not stimu-
late the phosphorylation of STAT1 (either on Tyr701 or Ser727)
or JAK family members (JAK1 and JAK2; Figure 1A). Dou-
ble immunofluorescence analysis demonstrated that low levels of
pSTAT3ser727 were constitutively present in the nuclei of SVZ neu-
ral cells and they did not change in the presence of the vehicle
(experimental control; Figures 1B,C). In contrast, IL-10 increased
the signal intensity of nuclear pSTAT3ser727 inNestin+progenitors
(Figures 1B,C).
ERK SIGNALING IS ACTIVATED BY IL-10 IN SVZ PROGENITORS IN VITRO
AND IN VIVO
Notch regulates cell survival in NSC cells by means of JAK-
independent activation of STAT3 through AKT and mTOR
Frontiers in Cellular Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 57 | 2
Pereira et al. IL -10 signaling on adult neurogenesis
FIGURE1 | Interleukin-10 increasesserineSTAT3phosphorylation in
Nestin+SVZprogenitors. (A)PhosphorylationofSTAT3Ser727 was induced
from5minafter IL-10 (50ng/mL) addition inprimaryculturesof theSVZ.
StimulationofpSTAT3Tyr701,STAT1, andJAK1andJAK2werenotobserved
(n=6per timepoint). (B)Double-immunofluorescencesstainingsshowthat
STAT3Ser727 immunoreactivity (green)was increased inNestin+progenitors
(red) in IL-10stimulatedcultures (30minafter administration), comparedwith
vehicle treatment (control).TO-PRO(blue) labeledall nuclei. (n=5). (C)
Histogramrepresents thenuclear immunoreactivity intensityofSTAT3Ser727
perNestin+cells in control andafter IL-10stimulation.After IL-10stimulation
phosphorylationofSTAT3Ser727 wasexacerbated inNestin+progenitors
(n=4).Scalebar (B), 30μm.Dataare representedasmean±SEM.*P ≤0.05.
FIGURE 2 | Interleukin-10 induces the activation of ERK p42–44
specifically in Nestin+ progenitors on SVZ primary cultures. (A) ERK1/2
Phosphorylation was induced from 5 min after IL-10 addition in primary
cultures of the SVZ (n = 5). (B) Duble-immunofluorescences stainings show
that the number of positive cells for phosphorylated ERK1/2 (green) is
increased after IL-10 stimulation compared with control. ERK1/2
Phosphorylation is restricted to Nestin+ progenitors (red) in both control and
under IL-10 presence. TO-PRO (blue) labeled all nuclei. (C) Histogram
represents the percentage of double-labeled cells (pERK+/Nestin+) in cells
that received the vehicle (control) or IL-10 for 30 min. After IL-10 stimulation
the phosphorylation of STAT3Ser727 was activated in the majority of Nestin+
(n = 4). Scale bar, 30 μm. Data are represented as mean ± SEM. **P ≤ 0.01.
phosphorylation (Androutsellis-Theotokis et al., 2006). In cell car-
cinomas, IL receptors activate STAT3 phosphorylation by JAK
and/or MAPKs (Lee et al., 2006). Stimulation assays with IL-
10 in SVZ cell cultures showed a rapid and strong induction
of ERK1/2 phosphorylation (Figure 2A). pERK1/2 was present
only in a small number of Nestin+ cells in the experimental con-
trol, as shown by double-immunofluorescence analysis. The acute
presence of IL-10 induced a robust increase in the number of
Nestin+ cells showing ERK1/2 phosphorylation (Figures 2B,C).
The stimulation of ERK1/2 phosphorylation was restricted to
Nestin+ progenitors and pERK1/2 was not detected in Nestin
negative cells. We conclude that IL-10 targets specifically Nestin+
progenitors, in which promotes ERK1/2 activation. In contrast,
AKT phosphorylation was not affected by the treatment with the
cytokine (data not shown). The same situation was observed in
vivo after acute treatment of adult mice with IL-10. A single
ICV administration of IL-10 into the LV of the mice induced
ERK1/2 and pSTAT3ser727 phosphorylation in the SVZ niche
of both hemispheres, ctr and ipsilateral to the injection site
(Figure 3A). Further studies on SVZ histological sections by
double immunofluorescences revealed that IL-10 induced rapid
pERK1/2 activation in Nestin+ progenitors and Mash1+ (TAPs)
cells (Figure 3B). We were unable to assess the presence of
pSTAT3ser727 in vivo since the antibodies available did not work
on brain sections.
Systemic administration of IL-10 to the mice also activated
intracellular pathways in the SVZ. Intravenous femoral admin-
istration of IL-10 induced rapid phosphorylation (30 min after
administration) of ERK in the SVZ niche in a dose-dependent
manner (Supplementary Figure S1)
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FIGURE 3 | In vivo IL-10 induces the phosphorylation of ERK and
STAT3. (A) Phosphorylation of ERK1/2 and STAT3ser727 in the ipsilateral (Ip)
and contralateral (ctr) SVZ niche of adult mice 30 min after they received an
ICV injection of IL-10 (1 ul of 50 ηgr/ml; n = 3). (B) Pictures of dorsal SVZ after
ICV IL-10 injection. ERK1/2 phosphorylation (green) takes place rapidly
(30 min) in Nestin+ (red) and Mash1+ (red) progenitors cells in dorsal SVZ
after in vivo IL-10 stimulation. To-pro (blue) stained all nuclei (n = 3). Scale bar,
30 μm.
All together, these data demonstrate that IL-10 activates ERK1/2
in vivo and in vitro and point to a subsequent activation of STAT3
on ser727 phosphorylation.
ERK1/2 ACTS UPSTREAM OF STAT3 ON SVZ PROGENITORS AND
MEDIATES THE BIOLOGICAL ACTION OF IL-10 BOTH IN VIVO AND IN
VITRO
Inhibition of the MAPK pathway by the MEK1/2 inhibitor U0126
prevented the induction of pSTAT3ser727 by IL-10 in SVZ primary
cells (Figure 4A), thereby strongly suggesting that ERK1/2 activa-
tion is required for STAT3 phosphorylation. In a previous study
we described that IL-10 modulates the undifferentiated state of
SVZ neural progenitors by up-regulating neural markers, such
as Nestin, Musashi, and NICD, while it decreases the expres-
sion of NUMB, a protein involved in neuronal differentiation
(Perez-Asensio et al., 2013). Inhibition of the MAPK pathway
abolished the IL10-mediated induction of the pro-neural markers
Musashi and NICD and reduced NUMB expression (Figure 4B).
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FIGURE 4 | ERK1/2 acts upstream of STAT3 and mediates IL-10
actions on SVZ progenitors. (A) MAPK pathway inhibition by U0126
(25 μM) prevents STAT3Ser727 activation induced by IL-10. Actin was the
loading control (n = 4). (B) Western blotting of neural protein expression
after U0126 treatment during 48 h. UO126 prevents the up-regulation of
Musashi, NICD and Numb induced by IL-10 (n = 4) (C) Pictures of
dissociated cultures stain against Nestin and TUBB3 in the presence of
IL-10 or IL-10+U0126. MEK inhibitor induced a decrease in the number of
progenitors (Nestin+) and increases the number of neuroblasts (TUBB3+).
Hoechst (blue) stained all nuclei. (D) Graph summarizes the effect of
U0126 on the numbers of Nestin+ and TUBB3+ cells in the control
situation and after IL-10 treatment. In control and IL-10-treated cultures
U0126 reduced the presence of Nestin+ cells while it increased
neuroblast number (TUBB3+). Values are expressed as the percentage of
control (n = 5). Scale bar: 30 μm. Data are represented as the
mean ± SEM. *P < 0.05.
Further analysis at the cellular level demonstrated that inhibi-
tion of ERK1/2 phosphorylation had considerable effects on the
expression of neural markers. Indeed, U0126 induced a significant
decrease in the number of Nestin+ cells, with a parallel increase
in TUBB3+ cells (Figures 4C,D). This alteration was observed in
control and IL-10-treated cultures, thus indicating that theERK1/2
pathway not only is functional under basal conditions but it also
mediates the biological effects induced by IL-10. Given that the
ERK signaling pathway is involved in CNS specification of glial
progenitors (Wang et al., 2012), we evaluated the effects of ERK
inhibition on glial phenotype markers. In this regard, we observed
that the number of GFAP+ cells was unaltered by the presence of
the inhibitor in any condition, while the number of Olig2+ cells
was reduced, independently of the presence or absence of IL-10
(Supplementary Figure S2).
In order to explore the relevance of the activation of ERK
signaling by IL-10 in vivo, we infused mice via ICV administra-
tion with the MAPK inhibitor U0126 in combination with IL-10
(IL-10 gain) or vehicle. We used a very low dose of this drug to
avoid secondary and unspecific effects of MAPK inhibition unre-
lated to IL-10 activity, since abnormalities in brain and cell fate
specification of CNS progenitors have been reported in several
contexts as a result of ERK signaling pathway alterations (Wang
et al., 2012). As expected, the inhibitor attenuated the phospho-
rylation of both ERK1/2 and STAT3 on Ser727 after 30 min of
IL-10 or vehicle treatment (Figure 5A). In contrast, the expression
of total STAT3 and Actin (as a loading control) was unchanged.
The administration of the inhibitor over several days did not
affect cell survival or proliferation (see Materials and Methods).
Cell number counts in brain sections were performed in order to
examine the effects of the inhibitor on the population of undif-
ferentiated progenitor cells. The MAPK inhibitor prevented the
improvement in the number of cells in the active cycle (KI67+,
Figure 5B) and the up-regulation of Nestin+ and Mash1+ pro-
genitor numbers induced by IL-10 (Figure 5C), thus indicating
that regular cellular differentiation was re-established. In addi-
tion, the ERK inhibitor abolished the detrimental effect of IL-10
on the presence of DCX+ neuroblasts, thereby showing that neu-
ronal determination was re-establish when ERK phosphorylation
was inhibited. With this experimental approach, no alterations in
Olig2 cell numbers was detected in the presence of U0126 (data
not shown).
All together, these results show that ERK1/2 activationmediates
IL-10 signaling in progenitors of the adult SVZ niche.
THE DOWN-REGULATION OF STAT3 EXPRESSION REVERSED THE
EFFECTS OF IL-10 ON SVZ PROGENITORS
Several inhibitors of STAT3 were evaluated in SVZ-dissociated
cultures. However, all of them compromised the viability of the
cultures even when used at very low doses, below their phar-
macological activity. To overcome this problem and rule out
the relevance of STAT3 in IL-10 signaling both in vivo and
in vitro, lentiviral vectors encoding a GFP reporter together
with a miRNA-embedded shRNA sequence targeting STAT3
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FIGURE 5 |The in vivo inhibition of ERK signaling abolish the
up-regulation ofTAPs induced by IL-10. (A)Western blot shows that
UO126 prevents the action of IL-10 on ERK1/2 and STAT3ser727
phosphorylation after 30 min of ICV administration. Expression of STAT3
and actin were unchanged (n = 3). (B) Pictures of SVZ niche in the
presence of IL-10 plus inhibitor or respective vehicle. The presence of the
inhibitor decreased the number of Ki67+ cells (green). (C) Histograms
summarize the number of cells present in dorsal SVZ per section. As
previously described Nestin+, Ki67+, and Mash1+ cells were increased
and DCX + cells were reduced in dorsal SVZ on IL-10-treated animals [6];
and U0126 abolished the actions of the cytokine (n = 4). Scale bar: 50 μm.
Data are represented as mean ± SEM. *P < 0.05.
(Lent-GFP-miSTAT3) or a control shRNA (Lent-GFP-miCont)
were designed and prepared (see Materials and Methods). The
efficiency to silence STAT3 was checked in several primary
cultures, including SVZ primary cultures, in which a con-
siderable reduction in total STAT3 levels was observed (see
Supplementary Figure S3A) taking into account that the trans-
duction efficiency varied between 30 and 40% (See Supplementary
Figure S3B).
In SVZ neural cultures, transduction with Lent-GFP-miSTAT3
attenuated the general IL-10-induced expression of genes like
Musashi and NICD, as markers of progenitor undifferentiation,
and NUMB expression was recovered (Figure 6A). Evaluation
of some of these markers at the cellular level demonstrated
that treatment with IL-10 reduced the number of neurob-
lasts (TUBB3+ cells, Lent-GFP-miCont cultures, Figures 6B,C),
as expected. In contrast, the presence of Lent-GFP-miSTAT3
reverted the effects of IL-10, and the number of neuroblasts
(red, TUBB3+ cells; Figures 6B,C) among transduced cells was
similar to those detected in Lent-GFP-miCont cultures (green,
arrows Figures 6B,C). In untreated cultures, the down-regulation
of STAT3 expression increased neuroblast numbers, thereby
suggesting that thismoleculewas specifically required for neuronal
differentiation. In all the experimental conditions, the numbers
of Olig2+ cells (Figure 6C) and astrocytes (GFAP+ cells, data
not shown) were not altered by STAT3 down-regulation. This
observation thus indicates that the differentiation of these cells
is not dependent on STAT3.
All together, these results support the requirement of STAT3
to mediate the function of IL-10 as a neurogenic factor and
its involvement in the regular neuronal differentiation of SVZ
progenitors.
Next, we assayed the effect of STAT3 down-regulation in a
physiological context. For this purpose, either control or STAT3-
shRNA lentiviral vectors were administered in vivo in the ctr
hemisphere by adding the lentiviruses to the osmotic mini-
pump implanted for IL-10 administration. Inhibition of STAT3
expression (Lent-GFP-miSTAT3) improved the determination of
the neuronal phenotype previously impaired by IL-10 treatment
(Figures 6D,E). This finding supports the notion that STAT3 is
required for IL-10 activity. All together, our results demonstrate
that STAT3 regulates adult neurogenesis in vivo andmediates IL-10
function.
DISCUSSION
The SVZ niche has a particular regional brain localization, allow-
ing a complex network of interactions between neighboring cells,
the vasculature, and the CSF. Molecular signals provided by this
rich environment regulate cell identity and renewal, and the pro-
liferation and differentiation of the resident progenitors (Merkle
et al., 2004). In a previous study, we identified the cytokine IL-10
as a key factor that regulates adult neurogenesis through a mecha-
nism of action independent of its well-known anti-inflammatory
properties (Perez-Asensio et al., 2013). In the present study we
deciphered the intracellularmolecular pathways activated by IL-10
on dorsal SVZ progenitors to exert its anti-neurogenic properties.
Our results demonstrate that ERK and STAT3 are activated by IL-
10 inNestin+progenitors and are required for the anti-neurogenic
action exerted by IL-10 on these cells.
The IL receptor signals through the activation of the JAK/STAT
pathway in several systems (Matsuda et al., 1999). IL-10-induced
STAT3 activation by the JAK1 adaptor is a key element mediating
its well-known anti-inflammatory properties (Lois and Alvarez-
Buylla, 1994; Matsuda et al., 1999; Levy andDarnell, 2002). During
mammalian cerebral cortical development, NSCs present in ger-
minal regions give rise to successive waves of neurons, followed
by oligodendrocytes and astrocytes, in a process orchestrated by
bone morphogenetic proteins (BMPs) and some cytokines (Bonni
et al., 1997; Mehler et al., 2000). Cytokine activation of JAK-STAT
signaling controls cell fate during mammalian development and
selectively enhances the differentiation of precursors along a glial
lineage (Mayer et al., 1994; Bonni et al., 1997; Nakashima et al.,
1999).
During CNS development, STAT3 phosphorylation is a domi-
nant signal for glial differentiation in the presence of ligands like
CNTF, LIF, Notch, and BMPs (Bonni et al., 1997; Aberg et al.,
2001). In addition, STAT3 has been reported to be an indispens-
able element for the maintenance and survival of embryonic and
NSCs (Matsuda et al., 1999; Raz et al., 1999; Foshay and Galli-
cano, 2008; Ying et al., 2008). STAT3 phosphorylation on Tyr705
by JAKs modulates the transcriptional activation of STAT3. How-
ever, it has been described that Notch signaling activates STAT3
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FIGURE 6 | STAT3 downregulation reverts the effects of IL-10 treatment
and improves neurogenesis in vitro and in vivo. (A) Western blotting of
neural protein expression after lentiviral transduction with Lent-GFP-micont
(miCont) or Lent-GFP-miSTAT3 (miSTAT3) treatment during 72 h.
miRNASTAT3 prevents the regulation of Musashi, NICD and Numb induced
by IL-10 (n = 4). (B) Pictures of dissociated cultures infected either by
miCont or miSTAT3 in the presence of IL-10 stained against TUBB3. STAT3
down-regulation induced an increase in the number of neuroblasts
(TUBB3+, red, arrows) among transduced cells (green). (C) Graph
summarizes the effect of STAT3 downregulation on the numbers of
TUBB3+, GFAP+, and olig2+ cells in control situation and after IL-10
incubation. Significant differences in the numbers of TUBB3 positive cells
were observed in IL-10-treated cultures by the presence of miSTAT3. Values
are expressed as the percentage of control (n = 5). (D) In vivo inhibition of
STAT3 expression on SVZ progenitors improves the number of
neuroblast-committed cells (DCX+ cells, red) on dorsal SVZ, 7 days after
lentiviral particles administration in vivo. (E) Graph represents the effect of
miSTAT3 in vivo. The alteration of STAT3 expression increases the presence
of DCX+ cells on the dorsal SVZ. Scale bar: 30 μm. Data are represented
as mean ± SEM. *P < 0.05.
FIGURE 7 | ERK1/2 and STAT3 mediate the actions of IL-10 to regulate
adult neurogenesis on adult SVZ. Schematic drawing summarizing the
findings reported in this work. IL-10 induces ERK1/2 and STAT3ser727
phosphorylation on Nestin+ cells. The activation of both intracellular
mediators leads to the accumulation of undifferentiated neural progenitors.
Conversely, when IL-10 levels are reduced the activity of ERK and STAT3 is
attenuated and neuronal differentiation is induced. The outcome is a higher
production of neurons.
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independently of the JAK pathway and mediates stem cell expan-
sion (Matsuda et al., 1999; Androutsellis-Theotokis et al., 2006).
In the present study, we found that IL-10 induces Ser727 phos-
phorylation on STAT3 in Nestin+ progenitors, while kinases of
the JAK family are not activated by this cytokine. Phosphory-
lation on Ser727 can be modulated by ERKs and other kinases,
such as mTOR. Our results suggest that IL-10-induced STAT3
activation in Nestin+ progenitors is mediated by ERK1/2. The
specific activation of this intracellular signaling pathway by IL-
10 in the adult SVZ induces notable changes the expression of
the Musashi/NUMB/Notch pathway, which regulates neural cell
status maintenance versus neuronal differentiation. Notch is a
critical element in the self-renewal and maintenance of NSCs
(Androutsellis-Theotokis et al., 2006; Andreu-Agullo et al., 2009;
Aguirre et al., 2010; Basak et al., 2012). NUMB inhibits Notch sig-
naling by binding to its intracellular domain, directing it into
degradation pathways, and it has been implicated in the regula-
tion of some aspects of neuronal differentiation. Musashi leads to
the down-regulation of NUMB by binding to its 3′ UTR mRNA
to inhibit translation (Imai et al., 2001; Li et al., 2003; Petersen
et al., 2004; Kuo et al., 2006). IL-10 signaling through ERK1/2 and
STAT3 causes marked changes in the NUMB-NOTCH-Musashi
pathway, leading to an undifferentiated stage in SVZ Nestin+ pro-
genitors as opposed to differentiation (Perez-Asensio et al., 2013;
present data).
Ras/ERK1/2 activity is critical during neurodevelopment and
brain tumor formation (Li et al., 2014). Constitutive activa-
tion of the MAPK signaling pathway promotes a pro-neural
genetic switch and induces glial differentiation in the develop-
ing embryonic brain (Samuels et al., 2008; Wang et al., 2012;
Li et al., 2014). The NF1 gene is a negative regulator of
Ras/ERK1/2 signaling, and NF1 inactivation impairs the balance
of glial versus neuronal output in the embryonic and postna-
tal brain. The neonatal inhibition of ERK1/2 activity reverses
the effects caused by NF1 inactivation (Wang et al., 2012). Our
data showed that IL-10 activates ERK and promotes a pro-
neural stage of Nestin+ progenitors of the adult SVZ, without
affecting glial differentiation. However, when ERK1/2 activity
was severely reduced by using high concentration of the phar-
macological inhibitor in vitro, oligodendroglial differentiation
was also impaired, independently of IL-10 activity. In con-
trast, the in vivo data showed no changes in the numbers of
Olig2 cells when the MAPK inhibitor was used at low concen-
trations sufficient to prevent the pro-neural state induced by
IL-10.
IL-10 levels control adult neurogenesis by regulating progenitor
differentiation (Perez-Asensio et al., 2013). Here we demonstrate
that ERK1/2 and STAT3 are activated by IL-10 and are mediators
of the effects of this cytokine in the dorsal SVZ. The induction of
ERK1/2 and STAT3 activity by IL-10 promotes an undifferentiated
stage in progenitor cells. Conversely, neuronal differentiation is
permitted in the presence of IL-10 when the activity of ERK1/2
and STAT3 is compromised (summarized in Figure 7).
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